Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fajgenbaum

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Blood Advances|September 1, 2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomesSheila K Pierson, Megan S Lim, Gordan Srkalovic, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Dysregulated lymphocyte localization in idiopathic multicentric Castleman diseaseMelanie D Mumau, Michael V Gonzalez, Katherine S Forsyth, et al.
Haematologica|September 11, 2025
Distinct interleukin-6 production in IPL and TAFRO subtypes of idiopathic multicentric Castleman diseaseAsami Nishikori, Midori Filiz Nishimura, Yoshito Nishimura, et al.
American Journal of Hematology|January 26, 2025
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution PatternsMizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, et al.
JCI Insight|May 8, 2020
Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman diseaseRuth-Anne Langan Pai, Alberto Sada Japp, Michael Gonzalez, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human diseaseJoshua D Brandstadter, Angelina De Martin, Mechthild Lütge, et al.
Frontiers in Immunology|April 4, 2025
Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patientsAllan Feng, Michael V Gonzalez, Muge Kalaycioglu, et al.
Blood|January 20, 2017
Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman diseaseLi Yu, Meifeng Tu, Jorge Cortes, et al.
European Journal of Immunology|June 27, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human diseaseJoshua D Brandstadter, Angelina De Martin, Mechthild Lϋtge, et al.
American Journal of Hematology|April 2, 2026
Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic StudyEmily Leung, Nicholas R Fragola, Elliott W Sharp, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Blood Advances|September 1, 2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomesSheila K Pierson, Megan S Lim, Gordan Srkalovic, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Dysregulated lymphocyte localization in idiopathic multicentric Castleman diseaseMelanie D Mumau, Michael V Gonzalez, Katherine S Forsyth, et al.
Haematologica|September 11, 2025
Distinct interleukin-6 production in IPL and TAFRO subtypes of idiopathic multicentric Castleman diseaseAsami Nishikori, Midori Filiz Nishimura, Yoshito Nishimura, et al.
American Journal of Hematology|January 26, 2025
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution PatternsMizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, et al.
JCI Insight|May 8, 2020
Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman diseaseRuth-Anne Langan Pai, Alberto Sada Japp, Michael Gonzalez, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human diseaseJoshua D Brandstadter, Angelina De Martin, Mechthild Lütge, et al.
Frontiers in Immunology|April 4, 2025
Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patientsAllan Feng, Michael V Gonzalez, Muge Kalaycioglu, et al.
Blood|January 20, 2017
Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman diseaseLi Yu, Meifeng Tu, Jorge Cortes, et al.
European Journal of Immunology|June 27, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human diseaseJoshua D Brandstadter, Angelina De Martin, Mechthild Lϋtge, et al.
American Journal of Hematology|April 2, 2026
Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic StudyEmily Leung, Nicholas R Fragola, Elliott W Sharp, et al.
Pageof 12